Patient Consent Form for the Use of GLP-1 Receptor Agonist :Semaglutide/Tirzepatide
I understand and acknowledge the following information before starting the use of GLP-1 Receptor Agonist: Semaglutide/Tirzepatide):
Warnings:
1. GLP-1 Receptor Agonist may cause tumors in the thyroid, including thyroid cancer. Symptoms to watch for include a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If any of these symptoms occur, I will inform my healthcare provider immediately.
2. I should not use GLP-1 Receptor Agonist if I or any of my family members have a history of medullary thyroid carcinoma (MTC), a type of thyroid cancer.
3. I should not use GLP-1 Receptor Agonist if I have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
4. I should not use GLP-1 Receptor Agonist if I have had a serious allergic reaction to tirzepatide or any of the ingredients in GLP-1 Receptor Agonist.
Possible Side Effects:
1. Severe stomach problems: I should inform my healthcare provider if I experience severe or persistent stomach problems.
2. Kidney problems: Diarrhea, nausea, and vomiting may lead to dehydration and kidney problems. I should ensure to drink fluids to prevent dehydration.
3. Gallbladder problems: I should immediately inform my healthcare provider if I experience symptoms such as upper stomach pain, fever, yellowing of skin or eyes, or clay-colored stools.
4. Inflammation of the pancreas (pancreatitis): If I experience severe stomach pain that does not go away, with or without vomiting, I should stop using GLP-1 Receptor Agonist and contact my healthcare provider immediately.
5. Serious allergic reactions: In case of symptoms such as swelling of the face, lips, tongue or throat, difficulty breathing or swallowing, severe rash or itching, fainting, dizziness, or rapid heartbeat, I should stop using GLP-1 Receptor Agonist and seek immediate medical help.
6. Low blood sugar (hypoglycemia): The risk of low blood sugar may increase if I use GLP-1 Receptor Agonist with certain other diabetes medications. Symptoms of low blood sugar include dizziness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, hunger, weakness, or feeling jittery.
7. Changes in vision in patients with type 2 diabetes: I should inform my healthcare provider if I experience any changes in vision during treatment with GLP-1 Receptor Agonist.
8. Depression or thoughts of suicide: I should pay attention to any changes in my mood, behaviors, feelings, or thoughts. If I notice any new, worsening, or concerning mental changes, I should contact my healthcare provider immediately.
Common Side Effects:
The most common side effects of GLP-1 Receptor Agonist include nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection site reactions, fatigue, allergic reactions, belching, hair loss, and heartburn. If any of these side effects bother me or do not go away, I should discuss them with my healthcare provider.
Before Using GLP-1 Receptor Agonist:
1. My healthcare provider will provide instructions on how to use GLP-1 Receptor Agonist before I start using it.
2. I should inform my healthcare provider if I am taking any diabetes medications, including insulin or sulfonylureas, as they may increase the risk of low blood sugar.
3. If I take birth control pills orally, I should consult my healthcare provider before using GLP-1 Receptor Agonist, as it may affect the effectiveness of birth control. Alternative forms of birth control may be recommended for a specific period.
4. I should discuss the following with my healthcare provider:
- Other medical conditions, including pancreas or kidney problems, or severe stomach issues such as gastroparesis or digestion problems.
- Other prescription medications, over-the-counter drugs, vitamins, or herbal supplements that I am currently taking.
- History of diabetic retinopathy.
- Pregnancy, plans to become pregnant, breastfeeding, or plans to breastfeed.
I confirm that I have read and understood the above information regarding GLP-1 Receptor Agonist (GLP-1 RA) and its potential risks and side effects. I have had the opportunity to discuss any concerns or questions with my healthcare provider. I voluntarily consent to the use of GLP-1 Receptor Agonist and agree to follow all instructions and guidelines provided.